Outpatient parenteral antimicrobial therapy for leishmaniasis: 13 years' experience at a large UK infectious diseases
Vivak Parkash1,2,3, Nicholas Laundy2, Oyewole Christopher Durojaiye2,3
1York Biomedical Research Institute, Hull York Medical School, University of York, York, UK.
Background:
Leishmaniasis is a neglected tropical disease that is imported by travellers returning to the UK. Given the prolonged therapy required, outpatient treatment has been proven to be cost-effective and safe.
Methods:
We describe cases of leishmaniasis treated through outpatient parenteral antimicrobial therapy (OPAT) over a 13-y period (March 2006-September 2018) at a large teaching hospital.
Results:
A total of 26 episodes of leishmaniasis were treated successfully, with a mean saving of 14.2 bed-days/episode. Sodium stibogluconate was the most used antileishmanial (92%).
Conclusions:
Treatment of chronic infections via OPAT is now commonplace and this approach may be considered for other imported infectious diseases.
More Related Videos
12:02An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity
Published on: November 2, 2016
06:57In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
Published on: February 20, 2020
Related Concept Videos
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
01:28Acute Pyelonephritis II: Diagnostic Studies and Management